Pfizer loses lawsuit over U.S. limits on drug copay assistance

A judge dismissed Pfizer Inc's (PFE.N) challenge to a U.S. anti-kickback law that the drugmaker said prevents it from helping Medicare patients afford two drugs that treat a sometimes fatal heart condition, but which cost $225,000 a year.